Abcodia | detecting cancer earlier
detecting cancer earlier


Abcodia has exclusive commercial rights to a serum biobank that allows discovery and validation of biomarkers of early disease formation. With annual sampling from healthy, the biobank provides a unique opportunity to generate data on disease detection years before standard diagnosis.

Between 2001 and 2005 202,600 women volunteers were enrolled into the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Volunteers donated a serum sample on trial entry and 50,000 women donated serum annually for up to 10 years.

The serum was collected to a rigorous protocol and is stored in liquid nitrogen at a commercial biobanking facility.

Abocodia Serum BankExtensive disease history

In addition to the samples, each volunteer has also provided information about demographics, lifestyle, and disease history and morphology.

Disease information is collected through the NHS Information Centre for Health and Social Care, Hospital Episode Statistics and death certificates. This data can be supplemented with additional disease data from UK General Practice and hospital medical records.

WWe can match healthy volunteers with benign and in-situ tumours as well as confounding diseases that could also affect biomarker levels, allowing studies to be truly representative of real-world populations.

Consented ethical approach

Volunteers have given their informed consent for the samples and data to be used for medical research (including research undertaken in collaboration with commercial organisations)

Entry Criteria
>50 years old, post-menopausal
Free from active cancer
No cancer history in previous 12 months
Volunteer data
Demographic and lifestyle information
NHS Information Centre for Health and Social Care (ONS)
NHS Hospital Episode Statistics records
GP and Consultant completed reports on outcomes and medical history

For more information on accessing the biobank, please email us at: